|
Stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumors: The RAPPORT trial. |
|
|
Honoraria - AstraZeneca; Roche (Inst); Varian Medical Systems (Inst) |
Consulting or Advisory Role - AstraZeneca; Janssen (Inst) |
Research Funding - Varian Medical Systems (Inst) |
Travel, Accommodations, Expenses - AstraZeneca (Inst) |
|
|
No Relationships to Disclose |
|
|
Research Funding - Telix Pharmaceuticals |
|
|
Employment - Genesis Cancer Care (I) |
Stock and Other Ownership Interests - ndirect - via Pension Funds; ndirect - via Pension Funds (I) |
|
|
Consulting or Advisory Role - Aduro Biotech (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); G1 Therapeutics (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst) |
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst); Seagen (Inst) |
|
|
Honoraria - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Merck Serono (Inst) |
Consulting or Advisory Role - Amgen |
Speakers' Bureau - Bristol-Myers Squibb; Merck; Roche/Genentech |
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Endocyte/Advanced Accelerator Applications (Inst); Genentech/Roche (Inst); Merck (Inst) |
Travel, Accommodations, Expenses - Roche/Genentech |
|
|
Honoraria - Amgen; Astellas Pharma; Janssen-Cilag; Sanofi; Tolmar |
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Ipsen; Ipsen; Janssen-Cilag; MSD Oncology; Sanofi; Tolmar |
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb; Genentech (Inst); Janssen-Cilag (Inst); Janssen-Cilag (Inst); Merck Sharp & Dohme; Merck Sharp & Dohme; Pfizer (Inst); Pfizer (Inst) |
Travel, Accommodations, Expenses - Amgen; Astellas Pharma |
|
|
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen; Merck Serono; Novartis; Pfizer; Sanofi; Telix Pharmaceuticals; Tolmar |
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Sanofi; Telix Pharmaceuticals; Tolmar |
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Serono; Novartis |
Research Funding - Aptevo Therapeutics (Inst); Astellas Pharma; Astellas Pharma (Inst); AstraZeneca; AstraZeneca (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Ipsen (Inst); MedImmune (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Synthorx (Inst) |
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Janssen; Merck Serono; Sanofi |
|
|
Consulting or Advisory Role - Bayer (Inst) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb |
Research Funding - Allergan; Bristol-Myers Squibb; Compugen; Roche/Genentech |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MedImmune; Roche/Genentech |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - Boston Scientific |
|
|
No Relationships to Disclose |
|
|
Honoraria - Astellas Pharma; AstraZeneca; Ferring; Ipsen; Janssen Oncology |
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer Schering Pharma; Janssen Oncology |
Travel, Accommodations, Expenses - Device Technologies |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - Roche |
|